Medic Life Sciences
1 known investors
Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Medic Life Sciences do?
- Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.
- Who are Medic Life Sciences's investors?
- Medic Life Sciences's investors include First In Ventures.